Murphy-Chutorian Douglas

CEO, interim CFO and Director, DirectorSemler Scientific, Inc. (SMLR) · full profile →Form 4 · filed Jan 16, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
1 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 16, 2026Disposed to issuer(D)241K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 16, 2026Disposed to issuer(D)125K$00
Jan 16, 2026Disposed to issuer(D)125K$00
Jan 16, 2026Disposed to issuer(D)15K$00
Jan 16, 2026Disposed to issuer(D)50K$00
Jan 16, 2026Disposed to issuer(D)15K$00
Jan 16, 2026Disposed to issuer(D)25K$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-004504) within minutes of acceptance. Every field above traces to the original document. Verify it directly: